DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
9.23
-0.37 (-3.85%)
At close: May 21, 2025, 4:00 PM
9.33
+0.10 (1.08%)
After-hours: May 21, 2025, 4:00 PM EDT
DBV Technologies Employees
As of December 31, 2024, DBV Technologies had 110 total employees, including 109 full-time and 1 part-time employees. The number of employees increased by 5 or 4.76% compared to the previous year.
Employees
110
Change (1Y)
5
Growth (1Y)
4.76%
Revenue / Employee
$31,791
Profits / Employee
-$1,033,200
Market Cap
253.00M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
DBVT News
- 5 days ago - Combined General Meeting of June 11, 2025 - GlobeNewsWire
- 15 days ago - DBV Technologies to Participate in the Citizens JMP Life Sciences Conference - GlobeNewsWire
- 21 days ago - DBV Technologies Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document - GlobeNewsWire
- 7 weeks ago - DBV Technologies ADRs Rise After Up to $306.9M in New Financing - Market Watch
- 7 weeks ago - DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved - GlobeNewsWire
- 2 months ago - DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results - GlobeNewsWire
- 3 months ago - DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress - GlobeNewsWire